Publicaciones en colaboración con investigadores/as de Universidad de Cantabria (8)

2017

  1. MIC of amoxicillin/clavulanate according to CLSI and EUCAST: Discrepancies and clinical impact in patients with bloodstream infections due to Enterobacteriaceae

    Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 5, pp. 1478-1487

2016

  1. CTX-M-15-H30Rx-ST131 subclone is one of the main causes of healthcare-associated ESBL-producing Escherichia coli bacteraemia of urinary origin in Spain

    Journal of Antimicrobial Chemotherapy, Vol. 71, Núm. 8, pp. 2125-2130

  2. Comprehensive clinical and epidemiological assessment of colonisation and infection due to carbapenemase-producing Enterobacteriaceae in Spain

    Journal of Infection, Vol. 72, Núm. 2, pp. 152-160

  3. Impact of the MIC of piperacillin/tazobactam on the outcome for patients with bacteraemia due to Enterobacteriaceae: The Bacteraemia-MIC project

    Journal of Antimicrobial Chemotherapy, Vol. 71, Núm. 2, pp. 521-530

2015

  1. Performance of EUCAST and CLSI approaches for co-amoxiclav susceptibility testing conditions for clinical categorization of a collection of Escherichia coli isolates with characterized resistance phenotypes

    Journal of Antimicrobial Chemotherapy, Vol. 70, Núm. 8, pp. 2306-2310

2014

  1. Detection of resistance to beta-lactamase inhibitors in strains with CTX-M beta-lactamases: A multicenter external proficiency study using a well-defined collection of escherichia coli strains

    Journal of Clinical Microbiology, Vol. 52, Núm. 1, pp. 122-129

2013

  1. The Spanish Antibiogram Committee (COESANT), in step with EUCAST

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 31, Núm. 10, pp. 639-640

2011

  1. Association of composite IS26-sul3 elements with highly transmissible IncI1 plasmids in extended-spectrum-β-lactamase-producing Escherichia coli clones from humans

    Antimicrobial Agents and Chemotherapy, Vol. 55, Núm. 5, pp. 2451-2457